๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to evaluate the safety, pharmacokinetics and p...
Status
Completed
Location
Jeonbuk National University Hospital
Start Date
2021-11-25
Trial ID
NCT05127746
Treatments Being Tested
The purpose of this study is to determine whether standard medications appr...
Status
Terminated
Location
Joseph & Kathleen Bryan Alzheimer's Disease Research Unit
Start Date
2006-10
Trial ID
NCT00369603
Treatments Being Tested
The purpose of the study is to test effectiveness of donepezil to improve w...
Status
Unknown
Location
University of Maryland Shore Medical Center at Easton
Start Date
2020-08-30
Trial ID
NCT04505670
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Multiple Locations
Start Date
2003-03
Trial ID
NCT01327859
Treatments Being Tested
This study is to compare the safety and effects of donepezil (Aricept) for ...
Status
Completed
Location
Kaiser Permanente-Anaheim
Start Date
2017-05-30
Trial ID
NCT02822573
Treatments Being Tested
The purpose of this study is to confirm bioequivalence between E2020 dry sy...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01506739
Treatments Being Tested
Alzheimer's disease (AD) is the main cause of dementia. At present, AD is i...
Status
Unknown
Location
Multiple Locations
Start Date
2021-12
Trial ID
NCT05114499
This research study will look at how medications affect the pattern of bloo...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT01379001
Treatments Being Tested
This study will evaluate acute symptomatic improvements in cognitive perfor...
Status
Terminated
Location
Multiple Locations
Start Date
2009-04-06
Trial ID
NCT00874939
Treatments Being Tested